Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLC

Anne Marie C. Dingemans*, Egbert F. Smit, Lizza E.L. Hendriks

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)381-382
Number of pages2
JournalThe New England journal of medicine
Issue number4
Publication statusPublished - 25 Jan 2024

Cite this